Melius Pharma

Stocksund, Sweden

Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases.

$1.8M raised

May 2022

Series A

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Fåhraeus Startup and Growth

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Melius Pharma

How much funding has Melius Pharma raised?

Melius Pharma has raised $1.8M in total funding. The most recent round was Series A. The last funding was announced in May 2022.

Who are Melius Pharma's investors?

Melius Pharma's investors include Fåhraeus Startup and Growth.

Where is Melius Pharma headquartered?

Melius Pharma is headquartered in Stocksund, Sweden.

What does Melius Pharma do?

Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases.

What stage is Melius Pharma at?

Melius Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 3, 2022.

MLA

"Melius Pharma — Funding & Investors." VCBacked, May 3, 2022, https://www.vcbacked.co/company/melius-pharma. Accessed July 3, 2026.

APA

VCBacked. (2022). Melius Pharma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/melius-pharma

Wikipedia (cite web)

{{cite web |title=Melius Pharma — Funding & Investors |url=https://www.vcbacked.co/company/melius-pharma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 3, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K